Cardiac device infections are associated with a significant mortality risk
Heart Rhythm, 04/18/2012
de Bie MK et al. – In a large cohort of patients who receive implantable cardioverter–defibrillator/cardiac resynchronization therapy–defibrillator after their initial implant, the 3–year incidence of Cardiac device infection (CDI) was 2.6%. The occurrence of CDI was associated with substantial 1–year mortality, and patients experiencing CDI had a more than 2–fold increased risk of mortality compared with patients who remained free from CDI.